The concern Garcia-Bunluel expresses regarding the possibility that our results may be confounded by interactions between the paralytic we used and the specific substances under study is important and addresses an issue that is often ignored in pharmacological experiments. However, the gallamine-dopamine interaction hypothesized by Garcia-Bunluel is extremely unlikely.
in order.
Because charged molecules cross lipid membranes with difficulty, substances containing one quaternary amino group usually do not cross the blood-brain barrier in pharmacologically significant amounts (1); gallamine contains three quaternary amine groups. Thus, radioactively labeled gallamine has been shown not to enter the central nervous system (CNS) (2) . However, some of the papers referred to by Garcia-Bunluel do present evidence that small amounts of gallamine may enter the CNS, and this possibility must be considered. In our case, however, even the crossing of gallamine into the brain could not have confounded our results, as shown below.
The references given by GarciaBunluel for dopamine-acetylcholine interactions deal with muscarinic drugs, whereas gallamine is a nicotinic antagonist. The paper referenced by GarciaBunluel to argue for anatomical dopamine-acetylcholine overlap shows the substantia nigra to have one of the lowest concentrations of acetylcholine in the brain. Although acetylcholinesterase is found in substantia nigra, it is well rec- ognized that it is not a reliable marker for acetylcholine input (3). Even if gallamine did affect the nigrostriatal system directly, a direct action of gallamine at the dopamine receptor must be hypothesized in order to confound our results, because microiontophoresis allows one to study the direct effect of dopamine on neurons. To our knowledge, no evidence has been advanced relating an interaction of acetylcholine with dopamine receptor sensitivity.
In addition, we have found that the dose response curves for dopamine neuron activity in rats with respect to apomorphine and dopamine are the same whether the animals are anesthetized with chloral hydrate or paralyzed with gallamine. Intravenous administration of gallamine to a respirated rat anesthetized with chloral hydrate does not alter dopamine cell firing rate or pattern. Furthermore, cholinergic drugs (for example, scopolamine and physostigmine), which pass the blood-brain barrier more easily than gallamine, have no detectable effect on dopamine cell activity.
From these data we conclude that in our studies gallamine did not confound the results. 29 AHOD. We suggest a more detailed analysis of the significance of TH and ZH be made before any limnological conclusion about cause and effect be drawn. In particular, the stepwise regression analysis approach should be avoided.
We applied the Cornett and Rigler model with data from the Great Lakes. The predicted AHOD for Lake Michigan is 504 mg of 02 per square meter per day for a hypolimnion 70 m thick and a total phosphorus concentration of 8 mg/m3 (4); for Lake Superior the predicted AHOD is 486 mg of 02 per square meter per day for a hypolimnion 130 m thick and a total phosphorus concentration of 4 mg/m3 (5). We found that these predictions, although possible, are too high for both Lake Michigan and Lake Superior and have never been observed. Our conclusion is that the model appears very sensitive to ZH and yields high AHOD values for any lake with a hypolimnion over 50 m thick.
An additional but less important problem with the computational technique is the transformation of the ZH and TH variables. The transformed variables, although statistically correct (6) 
